Literature DB >> 18221867

A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma.

Christian C Abnet1, Neal D Freedman, Albert R Hollenbeck, Joseph F Fraumeni, Michael Leitzmann, Arthur Schatzkin.   

Abstract

The incidence of oesophageal adenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor. We examined the association between BMI and EADC, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in a cohort of approximately 500,000 people in the United States (US). We used Cox proportional hazards regression to estimate hazard ratios (HR) and 95% confidence intervals (CI) with control for many potential confounders. We found that compared to people with a BMI of 18.5-25kg/m2, a BMI > or = 35 was associated with significantly increased risk of EADC, HR (95% CI)=2.27 (1.44-3.59) and gastric cardia adenocarcinoma 2.46 (1.60-3.80), but not gastric non-cardia adenocarcinoma 0.84 (0.50-1.42). Using non-linear models, we found that higher BMI was associated with increased risk of EADC even within the normal BMI. Increased adiposity was associated with higher risk of EADC even within the normal weight range.

Entities:  

Mesh:

Year:  2008        PMID: 18221867      PMCID: PMC2350215          DOI: 10.1016/j.ejca.2007.12.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  24 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

2.  Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.

Authors:  Aoife M Ryan; Suzanne P Rowley; Anthony P Fitzgerald; Narayanasamy Ravi; John V Reynolds
Journal:  Eur J Cancer       Date:  2006-04-19       Impact factor: 9.162

3.  Body-mass index and symptoms of gastroesophageal reflux in women.

Authors:  Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

4.  A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).

Authors:  A H Wu; P Wan; L Bernstein
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

5.  Body size and composition and the risk of gastric and oesophageal adenocarcinoma.

Authors:  Robert J MacInnis; Dallas R English; John L Hopper; Graham G Giles
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

Review 6.  Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

7.  Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.

Authors:  Mats Lindblad; Luis A García Rodríguez; Jesper Lagergren
Journal:  Cancer Causes Control       Date:  2005-04       Impact factor: 2.506

8.  Relation of body mass index to cancer risk in 362,552 Swedish men.

Authors:  Claudine Samanic; Wong-Ho Chow; Gloria Gridley; Bengt Jarvholm; Joseph F Fraumeni
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

9.  Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates.

Authors:  Mats Lindblad; Weimin Ye; Anders Lindgren; Jesper Lagergren
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

10.  A case-control study of oesophageal adenocarcinoma in women: a preventable disease.

Authors:  K K Cheng; L Sharp; P A McKinney; R F Logan; C E Chilvers; P Cook-Mozaffari; A Ahmed; N E Day
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

View more
  58 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

3.  Height, weight, and body mass index associations with gastric cancer subsites.

Authors:  M Constanza Camargo; Neal D Freedman; Albert R Hollenbeck; Christian C Abnet; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2013-10-31       Impact factor: 7.370

4.  Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers.

Authors:  Shih-Wen Lin; Neal D Freedman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

5.  Carcinogenesis of Barrett's esophagus: a review of the clinical literature.

Authors:  Jiro Watari; Tadayuki Oshima; Hirokazu Fukui; Toshihiko Tomita; Hiroto Miwa
Journal:  Clin J Gastroenterol       Date:  2013-08-14

6.  The association between obesity factor and esophageal caner.

Authors:  Qi Chen; Hengguo Zhuang; Yanhui Liu
Journal:  J Gastrointest Oncol       Date:  2012-09

7.  Gastric cardia cancer: how much is it from fat?

Authors:  Preetika Sinh; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

8.  Age-specific trends in incidence of noncardia gastric cancer in US adults.

Authors:  William F Anderson; M Constanza Camargo; Joseph F Fraumeni; Pelayo Correa; Philip S Rosenberg; Charles S Rabkin
Journal:  JAMA       Date:  2010-05-05       Impact factor: 56.272

9.  Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2014-01-18       Impact factor: 3.452

10.  Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma.

Authors:  M Rutegård; H Nordenstedt; Y Lu; J Lagergren; P Lagergren
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.